Functional magnetic resonance imaging of effects of a nicotinic agonist in schizophrenia.
Tregellas JR, Olincy A, Johnson L, Tanabe J, Shatti S, Martin LF, Singel D, Du YP, Soti F, Kem WR, Freedman R.
Tregellas JR, et al. Among authors: singel d.
Neuropsychopharmacology. 2010 Mar;35(4):938-42. doi: 10.1038/npp.2009.196. Epub 2009 Dec 2.
Neuropsychopharmacology. 2010.
PMID: 19956085
Free PMC article.
Clinical Trial.